Original Article
Serum AKR1B10 predicts the risk of hepatocellular carcinoma – A retrospective single-center study
El AKR1B10 sérico predice el riesgo de carcinoma hepatocelular. Un estudio retrospectivo unicéntrico
Rongping Zhua,b,1, Juan Xiaoa,c,d,1, Diteng Luoa, Mingjun Donga, Tian Suna, Junfei Jina,c,d,
Corresponding author
a Laboratory of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Guilin Medical University, Guilin 541001, Guangxi, People's Republic of China
b Emergency Traumatic Surgery, The Affiliated Ganzhou Hospital of Nanchang University (Ganzhou People's Hospital), Ganzhou 341000, Jiangxi, People's Republic of China
c China-USA Lipids in Health and Disease Research Center, Guilin Medical University, Guilin 541001, Guangxi, People's Republic of China
d Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Guilin Medical University, Guilin 541001, Guangxi, People's Republic of China
Read
621
Timeswas read the article
127
Total PDF
494
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 5 | 0 | 5 |
| 2024 April | 14 | 7 | 21 |
| 2024 March | 11 | 5 | 16 |
| 2024 February | 3 | 0 | 3 |
| 2024 January | 16 | 1 | 17 |
| 2023 December | 15 | 2 | 17 |
| 2023 November | 8 | 3 | 11 |
| 2023 October | 10 | 5 | 15 |
| 2023 September | 6 | 3 | 9 |
| 2023 August | 7 | 1 | 8 |
| 2023 July | 3 | 1 | 4 |
| 2023 June | 23 | 3 | 26 |
| 2023 May | 39 | 0 | 39 |
| 2023 April | 38 | 0 | 38 |
| 2023 March | 30 | 3 | 33 |
| 2023 February | 39 | 4 | 43 |
| 2023 January | 24 | 8 | 32 |
| 2022 December | 21 | 8 | 29 |
| 2022 November | 14 | 5 | 19 |
| 2022 October | 10 | 7 | 17 |
| 2022 September | 14 | 4 | 18 |
| 2022 August | 8 | 8 | 16 |
| 2022 July | 12 | 5 | 17 |
| 2022 June | 11 | 7 | 18 |
| 2022 May | 14 | 10 | 24 |
| 2022 April | 11 | 4 | 15 |
| 2022 March | 13 | 7 | 20 |
| 2022 February | 33 | 5 | 38 |
| 2022 January | 29 | 4 | 33 |
| 2021 December | 12 | 7 | 19 |
| 2021 May | 1 | 0 | 1 |
Show all
